LiverRight and Aegle Medical Solutions, LLC have announced a strategic partnership aimed at expanding access to non-invasive liver assessment, specialist interpretation, diagnosis, and ongoing liver care for patients across the United States. The collaboration combines Aegle Medical's advanced liver assessment technology, including the Mindray Hepatus-Series Transient Elastography Diagnostic Ultrasound Systems, with LiverRight's national virtual liver clinic, which provides specialist interpretation and access to hepatology clinicians.
The partnership addresses a critical gap in liver disease management. Many adults in the U.S. live with undiagnosed liver disease, and access to hepatology specialists can be limited, particularly in certain communities. By integrating Aegle Medical's technology and support services with LiverRight's virtual care network, the two organizations aim to create a more connected pathway that helps healthcare organizations move patients efficiently from liver disease identification and non-invasive assessment to specialist interpretation, diagnosis, and longitudinal management.
For physicians, health systems, and independent practices, the partnership offers a way to establish or expand comprehensive liver disease programs without building every component internally. Aegle Medical provides a consultative approach to technology evaluation, implementation, clinical training, and ongoing customer support. LiverRight offers same-day interpretation services for liver elastography studies and same-week virtual access to its hepatology clinicians. LiverRight's Liververse™ referral system supports the care pathway by coordinating bloodwork, patient-reported outcomes, available imaging, diagnosis, and longitudinal disease management.
The Mindray Hepatus platform represents a significant advancement in non-invasive liver assessment. It introduces Visualized Transient Elastography (ViTE), which integrates real-time B-mode ultrasound visualization directly into the elastography examination. Unlike conventional transient elastography platforms that rely primarily on measurement data without real-time anatomical visualization, ViTE enables operators to see liver anatomy, identify the optimal measurement location, and visually guide each acquisition while obtaining quantitative liver stiffness and attenuation measurements. This evolution combines the efficiency of transient elastography with the clinical confidence of real-time ultrasound visualization in a single examination.
The Hepatus platform provides liver stiffness measurement (LSM) for fibrosis assessment and Liver UltraSound Attenuation (LiSA) for quantitative assessment of hepatic steatosis. The Hepatus 6 further expands capabilities by combining these with diagnostic ultrasound imaging, allowing clinicians to utilize the system for abdominal imaging, Doppler, spleen stiffness assessment, and intestinal ultrasound, depending on configuration. This versatility supports a broader range of hepatology and gastroenterology applications.
"Aegle Medical Solutions is helping hospital systems and independent practices nationwide address the significant number of adults living with undiagnosed liver disease in the United States," said Brandon Tudor, CEO of LiverRight. "By working together, we help practices bring advanced liver assessment into the outpatient setting, provide timely specialist interpretation, and move patients into the appropriate diagnostic and care workflow with greater efficiency."
Michael McTighe, President & CEO of Aegle Medical Solutions, commented, "This strategic partnership with LiverRight represents an important step forward in our shared vision of expanding access to liver disease detection and care within the communities we serve." He added that the model can be particularly valuable for communities where access to hepatology specialists may be limited, with the goal of helping providers identify liver disease earlier, improve access to specialist expertise, and create a better experience for patients and clinicians.
LiverRight has its own hepatologists and hepatology advanced practice providers licensed across all 50 U.S. states, supporting adult patients with conditions including MASLD/MASH, alcohol-associated liver disease, hepatitis B and C, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, and liver cancer diagnosis. The Aegle Medical–LiverRight relationship gives health systems, GI and hepatology practices, and independent providers a scalable approach to expanding liver services, combining advanced non-invasive liver assessment technology, implementation and clinical support, timely specialist interpretation, and a pathway to continued liver care—all under the provider's brand.
The partnership underscores a growing trend toward integrating advanced technology with virtual care networks to address chronic diseases. By making advanced liver assessment more accessible in outpatient settings and connecting it with specialist expertise, the collaboration aims to improve early detection, streamline care delivery, and ultimately enhance outcomes for patients with liver disease.
